Clinical, environmental and histological distribution of BRAF , NRAS and TERT promoter mutations among patients with cutaneous melanoma: a retrospective study of 563 patients*-Reference-Cited by-同舟云学术

Clinical, environmental and histological distribution of BRAF , NRAS and TERT promoter mutations among patients with cutaneous melanoma: a retrospective study of 563 patients*

Published:2020-07-21 Issue:3 Volume:184 Page:504-513
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Manrique‐Silva E.¹²,Rachakonda S.³,Millán‐Esteban D.⁴,García‐Casado Z.⁴,Requena C.²^ORCID,Través V.⁵^ORCID,Kumar R.³^ORCID,Nagore E.¹⁶^ORCID

Affiliation:

1. Escuela de Doctorado Universidad Católica de Valencia San Vicente Mártir Valencia Spain

2. Department of Dermatology Instituto Valenci Valencia Spain

3. Division of Molecular Genetic Epidemiology Division of Functional Genome Analysis German Cancer Research Center Heidelberg Germany

4. Department of Molecular Biology Instituto Valenciano de Oncologia (IVO) Valencia Spain

5. Department of Pathology Instituto Valenciano de Oncologia (IVO) Valencia Spain

6. School of Medicine Universidad Católica de Valencia San Vicente Mártir Valencia Spain

Funder

Instituto de Salud Carlos III

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.19297

Reference32 articles.

1. The Molecular Pathology of Melanoma: An Integrated Taxonomy of Melanocytic Neoplasia

2. The Genetic Evolution of Melanoma from Precursor Lesions

3. Frequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanoma: a meta-analysis

4. A Landscape of Driver Mutations in Melanoma

5. Distinct Sets of Genetic Alterations in Melanoma

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coexisting RET/PTC and TERT Promoter Mutation Predict Poor Prognosis but Effective RET and MEK Targeting in Thyroid Cancer;The Journal of Clinical Endocrinology & Metabolism;2024-05-13

2. Clinical, histological, and molecular differences in melanoma due to different TERT promoter mutations subtypes. A retrospective cross‐sectional study in 684 melanoma patients;Pigment Cell & Melanoma Research;2023-12-28

3. Genetic trio of BRAF and TERT alterations and rs2853669TT in papillary thyroid cancer aggressiveness;JNCI: Journal of the National Cancer Institute;2023-12-19

4. Molecular Profile of Subungual Melanoma: A MelaNostrum Consortium Study of 68 Cases Reporting BRAF, NRAS, KIT, and TERT Promoter Status;Dermatology;2023-11-02

5. pTERT C250T mutation: A potential biomarker of poor prognosis in metastatic melanoma;Heliyon;2023-08